Funding leverage Cure HHT has substantial revenue in the $50M-$100M range and actively funds research through seed money and partnerships. This indicates potential for sponsored research, grant consulting, and philanthropy-focused fundraising services to optimize ROI and expand grant management capabilities.

Clinical network growth Active expansion in care access through more HHT Treatment Centers and a patient registry suggests opportunities to offer EHR integration, registry analytics, patient recruitment services, and clinical trial support platforms to streamline site onboarding and data collection.

Partnership momentum Ongoing collaborations with industry players (Vaderis, Atavistik Bio, Diagonal Therapeutics) show a readiness to engage in research partnerships. This is a strong signal for offering partner enablement, data sharing frameworks, and collaboration management tools.

Knowledge and education Launches like the HHT Continuing Education Hub indicate a demand for accredited training and education programs. There is a sales angle for learning management systems, content licensing, and professional development solutions for healthcare providers.

Digital transformation A technology stack spanning Sage Intacct, Salesforce, WordPress, and marketing ad platforms alongside a website rebuild RFP signals a need for integrated tech modernization, CRM optimization, data analytics, and website/conversion optimization services.